Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis

We describe a parametric time‐to‐event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine‐kinase inhibitor nintedanib in two phase III studies (INPULSIS‐1/2). Parametric survival analysis was performed on time...

Full description

Bibliographic Details
Main Authors: Fei Tang, Benjamin Weber, Susanne Stowasser, Julia Korell
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:CPT: Pharmacometrics & Systems Pharmacology
Online Access:https://doi.org/10.1002/psp4.12485
id doaj-dc0a8deb55fd4386b42f8aeaef39bd7a
record_format Article
spelling doaj-dc0a8deb55fd4386b42f8aeaef39bd7a2020-11-25T01:29:41ZengWileyCPT: Pharmacometrics & Systems Pharmacology2163-83062020-02-0192879510.1002/psp4.12485Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary FibrosisFei Tang0Benjamin Weber1Susanne Stowasser2Julia Korell3Translational Medicine and Clinical Pharmacology Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield Connecticut USATranslational Medicine and Clinical Pharmacology Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield Connecticut USABoehringer Ingelheim International GmbH Ingelheim am Rhein GermanyTranslational Medicine and Clinical Pharmacology Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield Connecticut USAWe describe a parametric time‐to‐event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine‐kinase inhibitor nintedanib in two phase III studies (INPULSIS‐1/2). Parametric survival analysis was performed on time to first exacerbation (censoring on day 372), with univariate analysis to select statistically significant covariates (P = 0.05). Multivariate covariate models were developed using stepwise covariate modeling with forward inclusion (P = 0.05) and backward elimination (P = 0.01). Sixty‐three first exacerbation events were reported across 1,061 subjects in the INPULSIS studies. Baseline and decline of forced vital capacity (FVC)/percent‐predicted FVC (%pFVC), supplemental oxygen use, baseline CO diffusing capacity and age were statistically significant in the univariate analysis. The final covariate model included decline in FVC to week 52, baseline %pFVC, supplemental oxygen use, and age. The developed model may be used to identify patients at high risk of IPF exacerbations and accelerate development of novel treatments.https://doi.org/10.1002/psp4.12485
collection DOAJ
language English
format Article
sources DOAJ
author Fei Tang
Benjamin Weber
Susanne Stowasser
Julia Korell
spellingShingle Fei Tang
Benjamin Weber
Susanne Stowasser
Julia Korell
Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis
CPT: Pharmacometrics & Systems Pharmacology
author_facet Fei Tang
Benjamin Weber
Susanne Stowasser
Julia Korell
author_sort Fei Tang
title Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis
title_short Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis
title_full Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis
title_fullStr Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis
title_full_unstemmed Parametric Time‐to‐Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis
title_sort parametric time‐to‐event model for acute exacerbations in idiopathic pulmonary fibrosis
publisher Wiley
series CPT: Pharmacometrics & Systems Pharmacology
issn 2163-8306
publishDate 2020-02-01
description We describe a parametric time‐to‐event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine‐kinase inhibitor nintedanib in two phase III studies (INPULSIS‐1/2). Parametric survival analysis was performed on time to first exacerbation (censoring on day 372), with univariate analysis to select statistically significant covariates (P = 0.05). Multivariate covariate models were developed using stepwise covariate modeling with forward inclusion (P = 0.05) and backward elimination (P = 0.01). Sixty‐three first exacerbation events were reported across 1,061 subjects in the INPULSIS studies. Baseline and decline of forced vital capacity (FVC)/percent‐predicted FVC (%pFVC), supplemental oxygen use, baseline CO diffusing capacity and age were statistically significant in the univariate analysis. The final covariate model included decline in FVC to week 52, baseline %pFVC, supplemental oxygen use, and age. The developed model may be used to identify patients at high risk of IPF exacerbations and accelerate development of novel treatments.
url https://doi.org/10.1002/psp4.12485
work_keys_str_mv AT feitang parametrictimetoeventmodelforacuteexacerbationsinidiopathicpulmonaryfibrosis
AT benjaminweber parametrictimetoeventmodelforacuteexacerbationsinidiopathicpulmonaryfibrosis
AT susannestowasser parametrictimetoeventmodelforacuteexacerbationsinidiopathicpulmonaryfibrosis
AT juliakorell parametrictimetoeventmodelforacuteexacerbationsinidiopathicpulmonaryfibrosis
_version_ 1725095468888752128